The Import Condition

The Gulf Cooperation Council has built health systems that can perform world-first surgical procedures, sequence hundreds of thousands of genomes, and deliver care at quality benchmarks that rival the best in Europe and North America. What it cannot do is manufacture the reagents, instruments, and consumables that those systems run on every day. Every diagnostic test performed in a GCC hospital depends on a supply chain that originates somewhere else. In normal times that is an expensive inconvenience. In a supply disruption, a geopolitical shift, or a pandemic, it is a structural vulnerability with direct consequences for patients.

This book argues that the diagnostic supply chain is a sovereignty question, not a procurement one. It is also, for the first time, a solvable one.

The first part establishes the problem in full. The GCC has made serious commitments to health as both a social and an economic priority. National visions across all six countries name health among their core diversification objectives. Six parallel national genome programmes are underway simultaneously. Population biobanks are operational. Precision health institutes have been built. And yet diagnostic manufacturing, the industrial layer that would make all of this scientifically and strategically coherent, does not appear as a named target in any of the six national industrial strategies. This absence is the book’s central observation. The ambition is sovereign. The supply chain is not.

The second part examines what the GCC has already built that makes a diagnostic value chain possible. The genome programmes, the biobanks, the clinical infrastructure, the sovereign capital, and the generation of Gulf-trained scientists are not peripheral assets. They are the foundation that most regions attempting industrial transformation in health spend decades trying to create. The Gulf has them. The question is whether they are connected into a system that can produce an industry rather than remaining as parallel national investments that cannot yet reach each other.

The third part proposes how to build that system, at national level and across the GCC as a bloc. It covers the cluster architecture that can anchor manufacturing, the regulatory instruments that can convert six fragmented markets into a single regional one, the data infrastructure that makes Gulf population science industrially usable, and the investment thesis that makes the proposition actionable for the capital that needs to move. These are not recommendations to a government. They are a working blueprint from inside an active build.

The book is addressed to the decision-makers, scientists, investors, and builders who are in a position to act on it.